Literature DB >> 17084335

Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22,953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery database.

Urs F Giger1, Jean-Marie Michel, Isabelle Opitz, Devdas Th Inderbitzin, Thomas Kocher, Lukas Krähenbühl.   

Abstract

BACKGROUND: Reliable risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy would be extremely useful to optimize the clinical management. This study aimed to determine risk factors that can be used for predicting perioperative complications. STUDY
DESIGN: Possible risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy for acute and chronic cholecystitis were analyzed by a stepwise logistic regression model using data from the Swiss Association of Laparoscopic and Thoracoscopic Surgery (SALTS) database.
RESULTS: A total of 22,953 patients with a mean (+/-SD) age of 54.5+/-16.1 years (range 17 to 89 years) and a male-to-female ratio of 1:2, underwent elective (85%) and emergency (15%) laparoscopic cholecystectomy. Multivariable analysis showed that male gender (odds ratio [OR]=1.16; p<0.0001), duration of intervention (OR=1.68 per 30 minutes; p<0.0001), body weight (>90 kg versus<60 kg; OR=1.34; p<0.0001), and the surgeon's own experience (>100 versus 11 to 100 interventions; OR=1.36; p<0.0002) were independently associated with an increased intraoperative local complication rate. In addition, male gender (OR=1.21; p<0.02), age (OR=1.12 per 10 years; p<0.0001), intraoperative complications (OR=2.1; p<0.0001), conversion to open surgery (OR=1.25; p<0.01), American Society of Anesthesiologists risk score (ASA score III/IV versus I/II: OR=1.28; p<0.0005), body weight (<60 kg versus>90 kg; OR=1.53; p<0.007), emergency surgery (OR=1.36; p<0.003), and duration of surgery (OR=1.28 per 30 minutes; p<0.0001) were found to be associated with a higher incidence of postoperative local complications. Higher postoperative systemic complications were encountered with conversion (OR=1.5; p<0.0002), ASA score (III/IV versus I/II: OR=1.54; p<0.0001), emergency surgery (OR=1.41; p<0.001), and a prolonged intervention time (OR=1.16 per 30 minutes; p<0.0001).
CONCLUSIONS: For patients undergoing laparoscopic cholecystectomy (LC), the risk of possible perioperative complications can be estimated based on patient characteristics (gender, age, ASA score, body weight), clinical findings (acute versus chronic cholecystitis), and the surgeon's own clinical practice with LC. So in the likelihood of a case being a "difficult cholecystectomy," an experienced surgeon should be involved both in the decision-making process and during the operation. If LC lasts longer than 2 hours, the cumulative risk for perioperative complications is four times higher compared with an intervention that lasts between 30 and 60 minutes, independent of the surgeon's personal skills with LC.

Entities:  

Mesh:

Year:  2006        PMID: 17084335     DOI: 10.1016/j.jamcollsurg.2006.07.018

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  75 in total

1.  Surgical management of acute cholecystitis: results of a 2-year prospective multicenter survey in Belgium.

Authors:  Benoit Navez; Felicia Ungureanu; Martens Michiels; Donald Claeys; Filip Muysoms; Catherine Hubert; Marc Vanderveken; Olivier Detry; Bernard Detroz; Jean Closset; Bart Devos; Marc Kint; Julie Navez; Francis Zech; Jean-François Gigot
Journal:  Surg Endosc       Date:  2012-03-10       Impact factor: 4.584

2.  Original single-incision laparoscopic cholecystectomy for acute inflammation of the gallbladder.

Authors:  Kazunari Sasaki; Goro Watanabe; Masamichi Matsuda; Masaji Hashimoto
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Development of an ex vivo simulated training model for laparoscopic liver resection.

Authors:  Andrew Strickland; Katherine Fairhurst; Chris Lauder; Peter Hewett; Guy Maddern
Journal:  Surg Endosc       Date:  2010-11-12       Impact factor: 4.584

4.  The analysis of 146 patients with difficult laparoscopic cholecystectomy.

Authors:  Orhan Bat
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 5.  Management of acute cholecystitis in cancer patients: a comparative effectiveness approach.

Authors:  Thejus T Jayakrishnan; Ryan T Groeschl; Ben George; James P Thomas; Sam Pappas; T Clark Gamblin; Kiran K Turaga
Journal:  Surg Endosc       Date:  2014-04-01       Impact factor: 4.584

6.  Major bile duct injury requiring operative reconstruction after laparoscopic cholecystectomy: a follow-on study.

Authors:  Patrick J Worth; Taranjeet Kaur; Brian S Diggs; Brett C Sheppard; John G Hunter; James P Dolan
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

7.  The degree of gallbladder wall thickness and its impact on outcomes after laparoscopic cholecystectomy.

Authors:  Shankar R Raman; Dovid Moradi; Bassem M Samaan; Umar S Chaudhry; Kamal Nagpal; John Morgan Cosgrove; Daniel T Farkas
Journal:  Surg Endosc       Date:  2012-04-27       Impact factor: 4.584

8.  Increasing bile duct injury and decreasing utilization of intraoperative cholangiogram and common bile duct exploration over 14 years: an analysis of outcomes in New York State.

Authors:  Maria S Altieri; Jie Yang; Nabeel Obeid; Chencan Zhu; Mark Talamini; Aurora Pryor
Journal:  Surg Endosc       Date:  2017-07-19       Impact factor: 4.584

9.  Responsiveness and minimal clinically important differences after cholecystectomy: GIQLI versus SF-36.

Authors:  Hon-Yi Shi; Hao-Hsien Lee; Chong-Chi Chiu; Herng-Chia Chiu; Yih-Huei Uen; King-Teh Lee
Journal:  J Gastrointest Surg       Date:  2008-05-03       Impact factor: 3.452

10.  Primary versus delayed repair for bile duct injuries sustained during cholecystectomy: results of a survey of the Association Francaise de Chirurgie.

Authors:  Antonio Iannelli; Jacques Paineau; Antoine Hamy; Anne-Sophie Schneck; Caroline Schaaf; Jean Gugenheim
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.